Home › Funds › PSP Research LLC › EWTX

PSP Research LLC position in EWTX

EDGEWISE THERAPEUTICS INC · Health Care

PSP Research LLC reported holding 5,000 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$203K, representing 0.14% of its reported portfolio and ranking #37 among its reported holdings. PSP Research LLC has disclosed EWTX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)5.00K sh
Reported value held$203.00K
Portfolio Weight0.14%
First reportedQ1 2026
Last changeHold
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How PSP Research LLC's EWTX position evolved

PSP Research LLC first disclosed a stake in EWTX in Q1 2026 at 6,500 shares (US$205K). Across 3 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 5,000 shares valued at US$203K.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 6.50K $204.75K New
Q2 2026 5.00K $203.15K Reduce
Q3 2026 5.00K $203.00K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EWTX and 13F data

EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 48 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.5M), Paradigm Biocapital Advisors LP (US$415.1M), RA CAPITAL MANAGEMENT, L.P. (US$341.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EWTX

All EWTX fund holders →

FAQ

How long has PSP Research LLC held EWTX?

PSP Research LLC has disclosed EWTX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is PSP Research LLC's current position in EWTX?

As of Q3 2026, PSP Research LLC holds 5.00K shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $203.00K, representing 0.14% of its reported portfolio and ranking #37.

Has PSP Research LLC been buying or selling EWTX?

In the latest 13F filing (Q3 2026), PSP Research LLC held unchanged its position in EWTX.

Which other funds hold EWTX?

Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.